Skip to content

Clinical trials

Phase 3 Schizophrenia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: France Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20043
20062
20075
20082
20103
20116
20122
20132
20161
20172
20191
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen-Cilag International NV6
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Sumitomo Pharma America, Inc.6
Boehringer Ingelheim2
Denovo Biopharma LLC2
Eli Lilly and Company2
Hoffmann-La Roche2
Janssen Research & Development, LLC2
H. Lundbeck A/S1
Janssen-Cilag Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia35
Psychotic Disorders3
Autistic Disorder2
Bipolar Disorder2
Recurrence1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.